Two Sigma Securities, LLC Novo Nordisk A S Transaction History

Two Sigma Securities, LLC

$629 Million
Q3 2025

A detailed history of Two Sigma Securities, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Two Sigma Securities, LLC holds 18,291 shares of NVO stock, worth $886,381. This represents 0.16% of its overall portfolio holdings.

Number of Shares

18,291

Holding current value

$886,381

% of portfolio

0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$45.38 - $71.7 $830,045 - $1.31 Million	18,291 New	18,291 $1.01 Million
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $696,490 - $983,607	-8,194 Reduced 64.11%	4,588 $394,000
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $11.4 Million - $13.9 Million	-95,844 Reduced 88.23%	12,782 $1.52 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $2.28 Million - $2.73 Million	18,581 Added 20.64%	108,626 $15.5 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $8.34 Million - $11.1 Million	81,688 Added 977.48%	90,045 $11.6 Million

Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $4.49 Million - $5.4 Million	-51,178 Reduced 85.96%	8,357 $864,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $4.49 Million - $9.86 Million	49,392 Added 486.96%	59,535 $5.41 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $311,024 - $344,264	1,994 Added 24.47%	10,143 $1.64 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $1.08 Million - $1.3 Million	8,149 New	8,149 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $204,756 - $251,282	2,149 New	2,149 $214,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $229,119 - $276,960	2,461 New	2,461 $273,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $426,977 - $470,754	-6,704 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $392,452 - $455,469	6,704 New	6,704 $439,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $192,349 - $251,929	-3,889 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $253,488 - $296,193	-5,084 Reduced 56.66%	3,889 $225,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $130,687 - $146,879	2,749 Added 44.17%	8,973 $464,000
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $291,220 - $326,573	6,224 New	6,224 $318,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $293,438 - $333,774	-7,064 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $9,352 - $10,248	200 Added 2.91%	7,064 $333,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $304,006 - $346,082	6,864 New	6,864 $317,000

Others Institutions Holding NVO

# of Institutions

1,693

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Novo Nordisk A S Transaction History